Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

Genovese, Mark C., McKay, James D., Nasonov, Evgeny L., Mysler, Eduardo F., da Silva, Nilzio A., Alecock, Emma, Woodworth, Thasia, Gomez‐Reino, Juan J.·2008·Arthritis & Rheumatism
DOI 10.1002/art.23940

Cited by (759)

Items 701–759 of 759

  1. High-Dose Immunoglobulin G Suppresses Local Inflammatory Reaction and Facilitates Functional Recovery Following Olfactory System Injury
    M. Kobayashi, K. Nishida, E. Ishigami, K. Takeuchi · 2021
  2. Bioterapias en los reumatismos inflamatorios
    J. Damiano · 2021 · EMC - Podología
  3. Topische Medikamentenanwendung bei neuropathischen Schmerzen
    Heinrich Binsfeld · 2021 · Schmerzmedizin
  4. Biothérapies dans les rhumatismes inflammatoires
    J. Damiano · 2021 · EMC - Podologie
  5. Application features of biological therapy in patients with autoimmune diseases
    N. Kozak, Olena Barabanchyk, Mariia Sobchenko, N. Molochek, Nadiia Dolgaia, Y. Penchuk, G. Mykhalchyshyn · 2021 · Minerva Biotechnology and Biomolecular Research
  6. Coronavirus disease-19 in Hematology. The perspective of a middle-income country
    D. Gómez-Almaguer, L. J. Marfil-Rivera, O. Cantú-Rodríguez, C. Gutiérrez-Aguirre, P. Colunga-Pedraza, L. Tarín-Arzaga, A. G. León, J. Jaime-Pérez, E. L. Zertuche-González · 2020 · Revista Medicina Universitaria
  7. Intravenous tocilizumab in the management of rheumatoid arthritis: Clinical practice findings from a 6-month international, multicentre, observational study in Central America and the Caribbean
    A. Ortega-Gómez, A. Sanabría-Castro, Raúl Alpízar-Campos, G. Guerra-Bautista, José A. Méndez-Rodríguez, R. Muñoz-Louis, N. Chávez-Pérez, Erwin-Stuardo Cajas-Melgar, Edgardo González-Sevillano, Alejandra López-Barquero · 2020 · Revista Colombiana de Reumatología
  8. Clinical Efficacy and Safety of Tocilizumab in the Treatment of Seropositive Rheumatoid Arthritis Patients in India
    Abhishek Kumar, D. Bhakuni, K. Shanmuganandan, A. Hegde, V. Vasdev, M. Arjun, K. Kishore · 2020 · Indian Journal of Rheumatology
  9. Expert recommendations on the interleukin 6 blockade in patients with rheumatoid arthritis
    Jesús Tornero Molina, Alejandro Balsa Criado, F. B. Blanco García, Ricardo Blanco Alonso, S. Bustabad, Jaime Calvo Alén, H. Corominas, Antonio Fernández Nebro, J. R. Román Ivorra, R. Sanmartí · 2020
  10. IL-6R protective variant rs7529229 reduces interleukin-6 signaling and contributes to decreased ischemic stroke risk
    Haihua Zhang, Wenbo Zhao, Bian Liu, Tao Wang, Zhifa Han, Xunming Ji, Guiyou Liu · 2020
  11. COMPARATIVE STUDY OF EFFICACY AMONG TOCILIZUMAB, ETANERCEPT AND DISEASE MODIFYING DRUGS IN COMBINATION WITH METHOTREXATE: A SINGLE CENTER STUDY FROM LANZHOU, CHINA
    Manisha Bhochhibhoya, Hai-Li Shen, B. Vaidya · 2019 · International Journal of Latest Research in Science and Technology
  12. Cardiovascular Safety of Anti-TNF and Non-TNF Biological Therapy in Patients with Rheumatoid Arthritis
    C. Ancuța, C. Mihailov, E. Ancuta · 2018 · Newest Updates in Rheumatology
  13. Surgery for Multicentric Reticulohistiocytosis Associated with Arthritis Mutilans: A Case Report with 26-Years' Follow-up
    H. Kanazawa, A. Hara, Y. Maruyama, K. Kaneko · 2018
  14. The effect of tocilizumab on clinical signs and laboratory findings in rheumatoid arthritis patients resistant to methotrexate
    Elham Rajae, A. Bidari, Jafar Forghani Zadeh, A. Asilian, Shirin Azizidoost · 2017 · Comparative Clinical Pathology
  15. Ml28133 -A Multicenter, Open-Label, Long-Term Extension Study of WA 19926 to Describe Safety During Treatment with Tocilizumab in Patients with Early, Moderate to Severe Rheumatoid Arthritis
    Irena Kafedziska, Snezhana Mishevska-Perchinkova, Dubravka Antova, M. Nikolova, A. Stojanovska, Filip Guchev · 2017 · Macedonian Medical Review
  16. Optimizing biological treatments for rheumatoid arthritis
    K. Chatzidionysiou · 2016 · Scandinavian Journal of Rheumatology
  17. Artritis reumatoide del adulto: estrategias terapéuticas
    B. Combe, Cédric Lukas, J. Morel · 2016 · EMC - Aparato Locomotor
  18. ADVANCES IN THERAPIES FOR RHEUMATOID ARTHRITIS
    K. Chatzidionysiou · 2015 · WORLD SCIENTIFIC eBooks
  19. Problems of rheumatoid arthritis in the 21st century
    E. Nasonov · 2015 · Herald of the Russian Academy of Sciences
  20. Effects of Concomitant Conventional and Previous Biological Disease Modifying Anti-Rheumatic Drugs Treatment on the Efficacy of Tocilizumab to Induce Remission in Patients with Rheumatoid Arthritis An Observational Real-Life Study
    Kathrin St, M. Englbrecht, K. Krueger, W. Ochs, M. Schmitt-Haendle, H. Kellner, H. Tony, S. Kleinert, M. Feuchtenberger, F. Schuch et al. · 2015 · Rheumatology Current Research
  21. Diagnostics and environmental factors
    E. Toubi · 2015 · Immunologic research
  22. Hepcidin: a promising marker for differential diagnosis of anemia and macrophage activation syndrome in children with juvenile idiopathic arthritis
    A. Egorov, E. Fedorova, V. Chasnyk, M. Kostik, L. Snegireva, О. В. Калашникова, M. Dubko, V. Masalova, T. Likhacheva · 2014
  23. Toxidermie survenant sous tocilizumab au cours de la polyarthrite rhumatoïde
    M. Fechtenbaum, Christopher Banse, Pauline Boyard-Lasselin, V. Goëb · 2014
  24. 71. Tocilizumab (Actemra
    Graeme Jones, C. Ding · 2014
  25. Selected Topics in Rheumatoid Arthritis
    A. Tiliakos, Karen L. Law, A. Lipson · 2013
  26. Anti-rheumatic effects of Tripterygium wilfordii Hook F in a network perspective
    Haiyang Fang, Ting-Hong Yang, Yichuan Wang, Wei-Dong Zhang, Ga Yang, Jing Zhao, Yi Zhang · 2013 · International Conference on Systems Biology
  27. Méta-analyse sur l’efficacité clinique et radiographique des biothérapies dans la polyarthrite rhumatoïde chez des patients naïfs ou en réponse inadéquate au méthotrexate
    A. Pierreisnard, N. Issa, T. Barnetche, C. Richez, T. Schaeverbeke · 2013
  28. Appearance of non-rheumatoid arthralgia after tocilizumab treatment in patients with rheumatoid arthritis
    H. Uda, O. Saiki · 2013 · Scandinavian Journal of Rheumatology
  29. 2．IL-6 標的薬
    N. Nishimoto · 2013
  30. Extraskeletal Manifestations in Rheumatoid Arthritis - Clinical Cases
    Katarzyna Romanowska‐Próchnicka, Przemysław Rzodkiewicz, Marzena Olesińska, Dariusz Szukiewicz, S Maśliński · 2013 · InTech eBooks
  31. Rôle de l'arginase dans l'atteinte vasculaire associée à l'arthrite chez le rat
    Clément Prati · 2012 · theses.fr (ABES)
  32. PMS88 Mixed Treatment Comparison, Cost-Effectiveness Analysis and Budget Impact Model in the Treatment of Rheumatoid Arthritis After Failure of Conventional Dmard Therapy Using Comprehensive Bayesian Decision Analytical Modelling
    R. Launois, J. Le Moine, T. Huynh · 2012
  33. Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
    Toshio Tanaka, K. Hagihara, Y. Shima, M. Narazaki, A. Ogata, A. Kumanogoh · 2011 · Drug Development Research
  34. Tocilizumab for the Treatment of Adults with Moderate to Severe Rheumatoid Arthritis
    Marie Oy Yee Pang and Ernest Choy · 2011 · Clinical Medicine Reviews in Therapeutics
  35. Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
    S. Horton, M. Buch · 2011
  36. Arthritis, Obesity, Increased Cardiovascular Risk and Disability
    S. Chatterjee · 2011 · CRC Press eBooks
  37. La prise en charge de la polyarthrite rhumatoïde en 2011 : stratégie et utilité des nouveaux biomédicaments
    C. Varoquier, G. Harifi, E. Chatelus, C. Sordet, Hélène Chifflot, J. Gottenberg, J. Sibilia · 2011
  38. Inhibidor del receptor de la interleucina-6 en el tratamiento de la artritis reumatoide: seguridad y dosificación del tocilizumab
    M. Martínez-Morillo, D. Grados, Beatriz Tejera, A. O. Marqués · 2011
  39. Zona grave dans la polyarthrite rhumatoïde au cours d’un traitement par anti-IL6
    Zuzana Kubandova, Sylvain Mathieu, C. Pourtier, M. Soubrier · 2010
  40. Biologika und kardiovaskuläres Risiko
    I. Tarner, U. Müller-Ladner, C. Hamm · 2010 · Zeitschrift für Rheumatologie (Print)
  41. L’anémie de la polyarthrite rhumatoïde
    Charles Masson · 2010 · Revue du Rhumatisme
  42. New biologic for treating rheumatoid arthritis: clinical trial experience with tocilizumab
    P. Emery · 2010 · International Journal of Clinical Rheumatology
  43. Therapie der chronischen Entzündungsanämie – Eisen, Bluttransfusionen oder Erythropoetin?
    J. Kaltwasser · 2009
  44. An insilico analysis to check the effect of novel drug molecules with Interleukin-6 on Rheumatoid arthritis
    Parul Pal, Hemlata Sharma, B. Khan, N. Poddar · 2023 · PROCEEDINGS OF THE 11TH INTERNATIONAL ADVANCES IN APPLIED PHYSICS AND MATERIALS SCIENCE CONGRESS & EXHIBITION
  45. Protocol for Systematic Review and Meta-Analysis on the Efficacy and Safety of Tocilizumab
    A. Elnour, A. Sadeq, F. Farah, I. Khidir, Doaa A. Nassar, Islam Mohammed Abd Allah, Jamila Alaryani, Judit Don, M. Hassan, Nadeen T. Ali et al. · 2020
  46. Immunogénicité du tocilizumab chez des patients atteints de polyarthrite rhumatoïde
    J. Sigaux, M. Hamze, C. Daien, J. Morel, Roman Krzysiek, M. Pallardy, Bernard Maillère, X. Mariette, C. Miceli-Richard · 2018
  47. Cardiac Effects of Antirheumatic Drugs
    Zoltán Szekanecz · 2017 · Technical report
  48. Acute Phase Reactants and the Concept of Inflammation
    César E. Fors Nieves, Bruce Neil Cronstein, Amit Saxena · 2016 · Elsevier eBooks
  49. Tocilizumab-induced Transaminitis in a Seropositive Rheumatoid Arthritis Patient with Macrophage Activation Syndrome
    Byung-Woo Yoo, Cheol Keun Park, H. Yun, Daehoon Kim, S. Lee, Sang-Won Lee · 2016 · Ewha Medical Journal
  50. Biologic Therapies
    Robert A. Eisenberg, Edward M. Behrens · 2015 · Elsevier eBooks
  51. 71 – Treatment of Rheumatoid Arthritis
    James R. O'Dell · 2013 · Elsevier eBooks
  52. Evaluation eines neuen 7-Gelenke-Ultraschall-Scores zum Therapiemonitoring bei Patienten mit Rheumatoider Arthritis und Psoriasisarthritis mit Einzelgelenkanalyse
    B. Halbauer · 2012
  53. Le blocage de la vole de l’interleukine-6
    C. Masson · 2011
  54. Targeted Therapies in Autoimmune and Inflammatory Skin Disorders
    Rüdiger Eming, Ingo Helmut Tarner · 2011 · Springer eBooks
  55. New and upcoming biologic agents for rheumatoid arthritis.
    Craig J. Beavers, Aimee C. Adams, Kelly M. Smith · 2010 · Orthopedics
  56. Role of Angiogenesis in the Pathogenesis of Arthritis: Potential Therapeutic Applications
    S. Kiriakidis, E. Paleolog · 2010 · Springer eBooks
  57. Aktuelle internistische Literatur referiert und kommentiert
    H. Wandt, Nürnberg · 2009 · Medizinische Klinik
  58. Zellgerichtete Therapien in der Rheumatologie
    M. Wahle · 2009 · Arthritis und Rheuma
  59. Zytokinblockade zur Behandlung rheumatologischer Erkrankungen
    S. Unger, M. Pierer, U. Wagner · 2009 · Arthritis und Rheuma